Scientists have long searched for ways to treat Alzheimer’s disease, the most common form of dementia. Chief among these ...

Even in mice with existing amyloid plaques, one injection of the gene therapy was associated with a roughly 50 percent ...

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

Scientists at Washington University in St. Louis have engineered brain cells to hunt and destroy amyloid plaques, cutting toxic buildup by roughly half in aged mice with advanced Alzheimer’s-like ...

While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting ...

The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...

Researchers engineer CAR-astrocytes to target and remove amyloid plaques in Alzheimer’s, showing a 50% reduction in brain ...

Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the ...

Though there is so much to learn about the way Alzheimer's develops in the human brain, amyloid beta proteins have long been implicated in its advance. A new study has uncovered a previously unknown ...

New research supports the hypothesis that Alzheimer's disease is caused by a decline in levels of a protein called amyloid-beta. New research from the University of Cincinnati bolsters a hypothesis ...